PIK3CA and neoplasm: The edited peptides showed abundances elevated beyond normal levels (“over-editing”) in 7% of all tumours, which is a prevalence comparable to the most frequent neoantigen epitopes like PIK3CA H1047R, which is expressed in 4% of all tumours39.